Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.
Press releases published on July 15, 2025
BSTR Miner Cloud Mining Unveils Industry-First XRP Mining Service: Zero-Hardware Cloud Solution to Earn Ripple Network Rewards
GlobeNewswire
·
July 15, 2025
Los Angeles, USA, July 15, 2025 (GLOBE NEWSWIRE) -- Unlike traditional proof-of-work cryptocurrencies, BSTR Miner’s XRP mining leverages participation rewards from Ripple’s energy-efficient consensus protocol. The service connects users to enterprise-grade …
Neo Pepe Coin ($NEOP) Announces Massive Giveaway, Rewarding Early Community Members
GlobeNewswire
·
July 15, 2025
A Generous Initiative for Loyal Supporters ROAD TOWN, British Virgin Islands, July 15, 2025 (GLOBE NEWSWIRE) -- Neo Pepe Coin ($NEOP), one of this year's standout memecoins, has officially launched an expansive and exciting giveaway program. This generous …
SELLAS Meets All Primary Endpoints in Phase 2 Trial of SLS009 in r/r AML and Receives FDA Guidance to Advance into First-Line Therapy Study
GlobeNewswire
·
July 15, 2025
The Trial Exceeded Target Overall Response Rate (ORR) of 20%, with 44% Response Rate Among Patients with Acute Myeloid Leukemia-Myelodysplasia-Related Changes (AML MR) Treated at Optimal Dose of 30 mg Twice a Week (BIW) and 50% in AML MR with …
Sky Quarry Announces Strategic Digital Asset Initiative
GlobeNewswire
·
July 15, 2025
WOODS CROSS, Utah, July 15, 2025 (GLOBE NEWSWIRE) -- Sky Quarry Inc. (NASDAQ: SKYQ) (“Sky Quarry” or “the Company”), an integrated energy company focused on sustainable resource recovery, today announced a strategic initiative to establish a digital asset …
Hengrui Pharma and Kailera Therapeutics Report Positive Topline Data from Phase 3 Obesity Trial in China of Dual GLP-1/GIP Receptor Agonist HRS9531
GlobeNewswire
·
July 15, 2025
– Mean weight loss of 19.2% at 6 mg with no plateau in 48-week Phase 3 trial – – Favorable safety profile consistent with other GLP-1-based treatments – – Hengrui to submit NDA in China; Kailera plans to evaluate both higher doses and longer duration of …
Iovance Biotherapeutics Appoints Corleen Roche as Chief Financial Officer
GlobeNewswire
·
July 15, 2025
SAN CARLOS, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for …
Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025
GlobeNewswire
·
July 15, 2025
GAITHERSBURG, Md., July 15, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, August 6, 2025, at 5:00 pm eastern time to discuss the financial results for the second quarter of 2025. Participants can …
ZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay Area
GlobeNewswire
·
July 15, 2025
- Lucile Packard Children’s Hospital Stanford is ready to accept patients for ZEVASKYN treatment - - Abeona Therapeutics® and Stanford Medicine conducted research collaboration for more than a decade, culminating in U.S. Food and Drug Administration (FDA) …
BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer
GlobeNewswire
·
July 15, 2025
PHILADELPHIA and VANCOUVER, British Columbia, July 15, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to …
ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel
GlobeNewswire
·
July 15, 2025
FDA confirmed that eGFR slope is an acceptable surrogate endpoint for accelerated approval of rilparencel in patients with CKD and type 2 diabetes FDA also confirmed that the ongoing Phase 3 PROACT 1 study can be used for both accelerated approval and for …
Neuronetics Appoints New Chief Financial Officer
GlobeNewswire
·
July 15, 2025
Steven Pfanstiel, a seasoned financial executive with extensive medical technology and pharmaceutical experience, replaces Steve Furlong as Chief Financial Officer following previously announced succession process Neuronetics reiterates guidance for second …
Plus Therapeutics Presents ReSPECT-LM Clinical Trial Results for REYOBIQ™ in Patients with Leptomeningeal Metastases
GlobeNewswire
·
July 15, 2025
Presentation by trial principal investigator at the 2025 SNO/ASCO CNS Metastases Conference Plus will also host an educational symposium with leading experts titled, “Reimagining Your Approach to Leptomeningeal Metastases” HOUSTON, July 15, 2025 (GLOBE …
WestKam Gold Corp. Provides Update on Management Cease Trade Order, Announces Appointment of Interim CFO and Announces Private Placement
GlobeNewswire
·
July 15, 2025
Vancouver, BC, Canada, July 15, 2025 (GLOBE NEWSWIRE) -- WestKam Gold Corp. (TSXV:WKG) (the “Company” or “WestKam”), further to its news release of July 2, 2025 (the “MCTO Announcement”), provides an update with respect to the management cease trade order …
AAS MINER Launches AI-Powered Bitcoin Cloud Mining — Activate with BTC, ETH, DOGE, or XRP for Higher Returns
GlobeNewswire
·
July 15, 2025
LONDON, UK, July 15, 2025 (GLOBE NEWSWIRE) -- A Smarter Future for Bitcoin Mining Starts Now The landscape of Bitcoin mining is changing—fast. Gone are the days when mining was limited to tech-savvy users and expensive hardware. AAS MINER is ushering in a …
CGTN: Et inspirationsbrev: Xis ord giver genlyd i Kinas blomstrende filmindustri
GlobeNewswire
·
July 15, 2025
BEIJING, July 15, 2025 (GLOBE NEWSWIRE) -- I 1905 blev der optaget en 30-minutters sort-hvid filmrulle uden lyd af Peking-operaens mester Tan Xinpei, der optrådte som en general i "Dingjun Mountain" – Kinas første film nogensinde – hvilket indvarslede en æ …
CGTN: Ein inspirierender Brief: Xis Worte finden in Chinas florierender Filmindustrie Anklang
GlobeNewswire
·
July 15, 2025
PEKING, July 15, 2025 (GLOBE NEWSWIRE) -- Im Jahr 1905 wurde der Meister der Peking-Oper Tan Xinpei in einem 30-minütigen Schwarz-Weiß-Stummfilm in der Rolle des Generals in „Dingjun Mountain“ festgehalten – Chinas erstem Film überhaupt – und läutete damit …
CGTN: מכתב להשראה: דבריו של הנשיא שי מהדהדים ברחבי תעשיית הקולנוע המשגשגת של סין
GlobeNewswire
·
July 15, 2025
בייג'ינג, July 15, 2025 (GLOBE NEWSWIRE) -- ב-1905, סרט אילם בשחור-לבן בן 30 דקות תיעד את אמן האופרה של פקין טאן שינפיי מופיע כגנרל ב"הר דינגג'ון" (Dingjun Mountain) - הסרט הראשון אי פעם בסין - ופתח עידן של השמעת סיפורים חזותית עבור האומה. כעת, 120 שנה …
CGTN: Surat penuh inspirasi: Kata-kata Xi Jinping memberikan pengaruh luas di industri film Tiongkok yang tengah maju pesat
GlobeNewswire
·
July 15, 2025
BEIJING, July 15, 2025 (GLOBE NEWSWIRE) -- Pada tahun 1905, gulungan film hitam-putih bisu berdurasi 30 menit merekam penampilan maestro Opera Peking, Tan Xinpei, sebagai jenderal dalam "Dingjun Mountain" – film pertama yang pernah dibuat di Tiongkok – …
CGTN: Una lettera d'ispirazione: L'influenza delle parole di Xi nella fiorente industria cinematografica cinese
GlobeNewswire
·
July 15, 2025
PECHINO, July 15, 2025 (GLOBE NEWSWIRE) -- Nel 1905, un cortometraggio di 30 minuti muto e in bianco e nero, "Il monte Dingjun", segnò l'inizio della cinematografia cinese. Con protagonista il maestro dell'Opera di Pechino Tan Xinpei nei panni di un …
CGTN：感動的な手紙：中国の映画界を活気づける習主席の言葉
GlobeNewswire
·
July 15, 2025
中国 ・北京発, July 15, 2025 (GLOBE NEWSWIRE) -- 1905年、30分の無声白黒映画『定軍山 (Dingjun Mountain)』で、京劇の巨匠、譚鑫培 (Tan Xinpei) が将軍役を演じた様子が撮影され、中国初の映画が誕生、この国に映像による物語の時代が幕を開けた。 120年経った今、中国は『ナタ 魔童の大暴れ (Ne Zha 2 …